Drug Trial Radar · NCT01220167
Three-way Crossover Study Comparing Ondansetron ODFS Administered With and Without Water to Zofran ODT Without Water
Last checked: Nov 19, 2026Latest source record: Aug 18, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
18
Actual
Start
Aug 2008
Primary completion
Aug 2008
Study completion Aug 2008
Sponsor
- Lead sponsor
- Aquestive TherapeuticsIndustry
- Sponsor type
- Industry
- First posted
- Oct 13, 2010
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Crossover
- Masking
- None
- Primary purpose
- Other
- Who can join
- All sexes, from 18 years, up to 45 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This study conducted in healthy male and female adult participants compared the bioavailability and relative safety and tolerance of a single dose of ondansetron 8 mg Orally Dissolving Filmstrip (ODFS) administered under fasting conditions with and without water with that of a single dose of Zofran Orally Dissolving Tablets (ODT®) containing ondansetron 8 mg administered under fasting conditions without water.
Conditions
- Healthy Participants
Interventions
Ondansetron 8 mg ODFS without waterDrug
Single dose of Ondansetron 8 mg (ODFS) administered without water
Ondansetron 8 mg ODFS with waterDrug
Single dose of Ondansetron 8 mg (ODSF) was orally administered, allowed to dissolve, swallowed with saliva, followed with water
Zofran ODT (ondansetron 8 mg) without waterDrug
Single dose of Zofran ODT (containing ondansetron 8 mg) administered without water
Primary outcomes
What the sponsor says the trial is designed to measure.
- CmaxTime frame: 0, 1, 2, 3, 4, 6, 8, 12, 24, 48, 72, 96 hours post-dose
- AUCtTime frame: 0, 1, 2, 3, 4, 6, 8, 12, 24, 48, 72, 96 hours post-dose
- AUCinfTime frame: 0, 1, 2, 3, 4, 6, 8, 12, 24, 48, 72, 96 hours post-dose
Locations
No sites are listed on the registry yet.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.